Metronomic Capecitabine With Digoxin for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment

NCT01887288 Phase 2 TERMINATED Results posted

To evaluate the Growth Modulation Index (GMI) of the combination of metronomic capecitabine with oral digoxin in metastatic breast cancer

Details

Lead sponsor	Western Regional Medical Center
Phase	Phase 2
Status	TERMINATED
Enrolment	16
Start date	2013-04
Completion	2015-11

Conditions

• Metastatic Breast Cancer

Interventions

• Capecitabine
• Digoxin

Primary outcomes

• Metronomic Capecitabine With Oral Digoxin — One year
  Evaluate the Growth Modulation Index (GMI) of the combination of metronomic capecitabine with oral digoxin in metastatic breast cancer

Countries

United States